: Elon Musk has a habit of moving early into massive industries, then watching a stampede of money and competition follow. Now he’s targeting the intersection of AI and the human body, and Matt McCall breaks down why it could be his biggest opportunity yet.

And it’s already happening on two fronts at once…

Raytheon has posted a negative average return in exactly two months since 1993, and we’re sitting in that window right now. Here’s why this seasonal dip looks like a buying opportunity, not a warning sign, and the price levels we’re watching to add more.

The number on your statement isn’t always accurate…

The intersection of AI, genomics, and robotic surgery…

Raytheon builds about 60 Tomahawks a year. The Navy just signed a $22.9 billion contract to get that above 1,000, and the leveraged defense fund is sitting back at its June lows.

The next medical breakthrough might not come from a lab at all…

September is historically the weakest month for stocks, which is exactly when the best setups get built. Our team sent in four names this morning, and two analysts landed on the same one.

Almost everybody owns the riskiest asset in America. It’s federally insured, it pays interest, and it’s guaranteed to make you poorer every year you hold it. It’s your savings account. I know how that sounds, but let me explain. The United States owes $40 trillion. The economy grows at roughly half the rate that debt […]

Every time he’s made this move, it’s minted a new generation of millionaires…

Nate added to this position today across multiple strikes. He can’t name it here, but the chart is in the video.

For most investors, transformers, substations, circuit breakers, and switchgear aren’t exactly exciting BBQ conversation. But I’ve learned over the years that some of the best investment opportunities hide in boring places. And this week, Washington just gave us another reason to start paying attention to America’s electrical grid. President Trump signed an executive order Wednesday […]